APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM NEW
Total 13F shares
760,574
Share change
-1,964,255
Total reported value
$5,985,000
Price per share
$7.87
Number of holders
17
Value change
-$32,769,680
Number of buys
7
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q4 2021

As of 31 Dec 2021, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 760,574 shares. The largest 10 holders included VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, FRANKLIN RESOURCES INC, and STATE STREET CORP. This page lists 17 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.